Cancer immunology and immunotherapy at EACR 2027

Jun 14–17, 2027 Bilbao, Spain ~2.4k attendees Website

22 organizations at EACR 2027 present work in cancer immunology, immunotherapy and the tumour microenvironment, led by universities and institutes. Between them they bring 29 presentations to the program. Most represented: Institute for Research in Biomedicine (IRB Barcelona), Spanish National Cancer Research Centre (CNIO) and Memorial Sloan Kettering Cancer Center. As of Oct 13, 2026.

All 104 organizations at EACR 2027 →

Format
Top represented
Showing 1–17 of 22 organizations
OrganizationEACR 2027 Attendance
Universities & institutes
Biomedical research institute in Barcelona, Spain, with research programmes that include cancer science.
Talk
Tue Jun 15
11:35am–1:10pm
Title to be announced
Immunology · Therapy & resistance
Universities & institutes
Spain's public cancer research centre, with basic research, translational programmes and an experimental therapeutics programme.
Talk
Wed Jun 16
9:20–10:55am
Cancer centres & hospitals
NCI-designated comprehensive cancer centre in New York City for cancer care and research.
Plenary
Mon Jun 14
3:50–6:15pm
Universities & institutes
Private research university in Stanford, California, with a school of medicine.
Talk
Tue Jun 15
11:35am–1:10pm
Title to be announced
Immunology · Therapy & resistance
Plenary
Thu Jun 17
12:05–1pm
Cancer centres & hospitals
Translational cancer research institute on the campus of Vall d'Hebron University Hospital in Barcelona, Spain.
Talk
Wed Jun 16
11:35am–1:10pm
Talk
Wed Jun 16
3:20–4:55pm
Universities & institutes
Multidisciplinary research institute and graduate school in Rehovot, Israel.
Talk
Wed Jun 16
9:20–10:55am
Talk
Wed Jun 16
11:35am–1:10pm
Universities & institutes
International cancer research organisation running research branches and Ludwig Centers at universities in Europe and the United States.
Session
Mon Jun 14
3:45–6:15pm
Talk
Tue Jun 15
11:35am–1:10pm
Title to be announced
Immunology · Therapy & resistance
CU
Copenhagen University Hospital – Herlev
Herlev, Denmark
Cancer centres & hospitals
Public university hospital near Copenhagen, home to the National Center for Cancer Immune Therapy (CCIT-DK), which develops cell-based immunotherapies.
Cancer centres & hospitals
Harvard-affiliated cancer treatment and research center in Boston.
Cancer centres & hospitals
University hospital in Barcelona, Spain, whose academic programme has developed in-house CAR-T cell therapies.
Universities & institutes
Biomedical research institute linked to Hospital del Mar in Barcelona, Spain, with a cancer research programme.
Cancer centres & hospitals
Research hospital in Milan, Italy, combining patient care with biomedical research, including gene and cell therapy.
Talk
Wed Jun 16
9:20–10:55am
KU Leuven
Leuven, Belgium
Universities & institutes
Research university in Leuven, Belgium.
Lund University
Lund, Sweden
Universities & institutes
Public research university in Lund, Sweden; its Lund University Cancer Centre (LUCC) brings together cancer research groups.
Talk
Wed Jun 16
11:35am–1:10pm
Universities & institutes
Life sciences research institute in Beijing, China.
Cancer centres & hospitals
Comprehensive cancer centre in Amsterdam combining research labs with the Antoni van Leeuwenhoek hospital.
Universities & institutes
Public university in Barcelona, Spain, with a department of medicine and life sciences.

Explore the full EACR 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Bilbao. Leave your work email and we’ll be in touch.

Privacy

Download the full EACR 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers in cancer immunology, immunotherapy and the tumour microenvironment

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Browse EACR 2027 by

Exhibit hall

Not affiliated with or endorsed by the European Association for Cancer Research. Submit a correction